You may already be familiar with IGeneX's ImmunoBlots for Lyme disease, Tick-Borne Relapsing Fever, and COVID-19. Now, IGeneX is happy to announce that Bartonella (Bartonellosis) has joined the ImmunoBlot revolution.

ImmunoBlots use recombinant antigens to increase sensitivity, specificity and extend species coverage. They effectively replace the Western blot.

In this webinar, you will learn:
- Overview of what makes an ImmunoBlot a superior test
- Challenges of diagnosing Bartonella
- Deep dive into the Bartonella ImmunoBlot, and how this test is able to increase sensitivity and specificity
- Additional Bartonella tests to complement the ImmunoBlot

Featured Speaker:
Dr. Joseph Burrascano, Jr. MD
- IGeneX Consultant
- Well-known pioneer in the field of tick-borne diseases, active since 1985
- Founding member of ILADS and ILADEF
- Active in physician education on all aspects of tick-borne diseases

Dr. Jyotsna Shah from IGeneX joins during the Q&A.

свернуть